• Explore /
  • Poster
  • / Phase II study of chemoradiation plus bevacizumab (BV) for locally/regionally advanced nasopharyngeal carcinoma (NPC): Preliminary clinical results of RTOG 0615.

Phase II study of chemoradiation plus bevacizumab (BV) for locally/regionally advanced nasopharyngeal carcinoma (NPC): Preliminary clinical results of RTOG 0615.

Abstract Poster

Authors

null

N. Y. Lee

Memorial Sloan-Kettering Cancer Center, New York, NY

N. Y. Lee , Q. E. Zhang , A. S. Garden , J. J. Kim , D. G. Pfister , J. Mechalakos , K. Hu , Q. Le , B. S. Glisson , A. T. C. Chan , K. K. Ang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Head and Neck Cancer

Clinical Trial Registration Number

RTOG0615

Citation

J Clin Oncol 29: 2011 (suppl; abstr 5516)

Abstract #

5516

Poster Bd #

10

Abstract Disclosures

Similar Posters

First Author: Chong Zhao

First Author: Cathy Eng

First Author: Manabu Muto

First Author: Thiago Bueno Oliveira Sr.